Circulating biomarkers linked to mechanical thrombectomy outcomes in people with COVID-19

Takeaway

  • COVID-19 infection negatively impacts early clinical outcomes in people with acute ischemic stroke and large vessel occlusion treated with mechanical thrombectomy.

Why this matters

  • Clinical outcomes after mechanical thrombectomy for large vessel occlusion in people with COVID-19 are unknown. These important findings suggest that anomalies in lymphocyte count, and lactate dehydrogenase and aspartate levels could be used as biomarkers to predict post-procedure outcomes in infected people.